the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

France’s Ekitike ruled out of 2026 World Cup with injury

Liverpool forward Hugo Ekitike will miss the 2026 World Cup after suffering a serious Achilles injury, confirmed France coach Didier Deschamps.

LIVERPOOL and France forward Hugo Ekitike will miss the 2026 World Cup after suffering a serious injury in his club’s Champions League loss to Paris Saint-Germain, his national team coach Didier Deschamps said Wednesday.

The 23-year-old crumpled in a heap holding his lower right leg with a suspected ruptured Achilles tendon during the first half of Liverpool’s 2-0 quarter-final second-leg defeat to European champions PSG on Tuesday.

“Unfortunately, the severity of (Ekitike’s) injury will prevent him from finishing the season with Liverpool and taking part in the World Cup,” Deschamps said in a statement released by the French football federation.

“This injury is a huge blow for him, of course, but also for the French national team.

“I wanted to express my full support for him, as well as that of the entire coaching staff.”

Ekitike has scored 17 goals in 45 matches in all competitions for Liverpool since arriving at Anfield for a fee of £79 million ($105.5 million) last summer.

Since winning his first France cap in a World Cup qualifier in September last year, Ekitike has been a regular in Les Bleus’ set-up, scoring two goals and providing one assist in his eight caps.

“It looks really bad, but difficult for me to say how bad,” Liverpool manager Arne Slot said after Tuesday’s match.

Injuries have been a major factor in a disastrous season for Liverpool as they sit fifth in the Premier League and will end the campaign without silverware.

“Losing a player is something we have had many times this season, but it is especially hard for him because you never want to be injured, especially at this time of the season,” added Slot.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings